Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Alafenamide Fumarate
Generic Name: emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate
Dosage form: TABLET, FILM COATED. Active ingredients: EMTRICITABINE (200 mg/1); RILPIVIRINE HYDROCHLORIDE (25 mg/1); TENOFOVIR ALAFENAMIDE FUMARATE (25 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: TABLET, FILM COATED. Active ingredients: EMTRICITABINE (200 mg/1); RILPIVIRINE HYDROCHLORIDE (25 mg/1); TENOFOVIR ALAFENAMIDE FUMARATE (25 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as tablet, film coated.
Related Medications
Urtica Dioica
urtica dioica
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: URTICA DIOICA POLLEN (.05 g/mL). Category: BLA.
Anticoagulant Citrate Phosphate Dextrose Solution
anticoagulant citrate phosphate dextrose solution
MACO BIOTECH Collection - Sterile Cord Blood Collection Unit (MSC128D) The MSC128D Sterile Cord Blood Collection Unit consists of 300 mL collection bag containing 21 mL of Anticoagulant Citrate Phosphate Dextrose Solution USP (CPD), a 40 mL rinsing bag containing 8 mL of CPD and two 12 gauge needles with a protective shield (SECUVAM) for the used needle. Sterile, non-pyrogenic fluid path. Sterilized by steam. Rx only . This product is not made with natural rubber latex.
Camphor, Thuja, Lycopodium, Kali Brom, Baryta Crab, Phosphorus, Helonias
camphor, thuja, lycopodium, kali brom, baryta crab, phosphorus, helonias
Dosage form: LIQUID. Route: ORAL. Active ingredients: BARIUM CARBONATE (30 [hp_C]/30[hp_C]); CHAMAELIRIUM LUTEUM ROOT (30 [hp_C]/30[hp_C]); CINNAMOMUM CAMPHORA WHOLE (30 [hp_C]/30[hp_C]); LYCOPODIUM CLAVATUM SPORE (30 [hp_C]/30[hp_C]); PHOSPHORUS (30 [hp_C]/30[hp_C]); POTASSIUM BROMIDE (30 [hp_C]/30[hp_C]); THUJA OCCIDENTALIS LEAFY TWIG (30 [hp_C]/30[hp_C]). Category: UNAPPROVED HOMEOPATHIC.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.